University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Grand Rounds > PrEP in 2011
PrEP in 2011: Results from the iPrEx Study and Discussion of the Public Health Implications
greyline
transparent gif
transparent gif
Robert M. Grant, MD, MPH

Robert M. Grant, MD, MPH

Grant Colfax, MD

Grant Colfax, MD

Back to Grand Rounds
Video ClipWatch the Presentation Real Icon View in Real
SlidesView Slides Without Audio
Description
Dr. Grant, lead author of the iPrEx study, discusses the recently published results that demonstrated partial efficacy of antiretroviral medications as preexposure prophylaxis (PrEP) against HIV acquisition among high-risk HIV uninfected men who have sex with men (MSM) and transgendered women who have sex with men. Dr. Colfax discusses the implications of the iPrEx findings on comprehensive HIV prevention and care services, and considerations involved in implementing PrEP in community settings. Included in their presentation is information on factors associated with greater PrEP effectiveness, as well as on safety and drug resistance. For more information on the study see the iPrEx website.